A randomized phase III study of standard versus high-dose cytarabine with or without vorinostat for AML

Guillermo Garcia-Manero, Nikolai A. Podoltsev, Megan Othus, John M. Pagel, Jerald P. Radich, Min Fang, David A. Rizzieri, Guido Marcucci, Stephen A. Strickland, Mark R. Litzow, M. Lynn Savoie, Bruno C. Medeiros, Mikkael A. Sekeres, Tara L. Lin, Geoffrey L. Uy, Bayard L. Powell, Jonathan E. Kolitz, Richard A. Larson, Richard M. Stone, David ClaxtonJames Essell, Selina M. Luger, Sanjay R. Mohan, Anna Moseley, Frederick R. Appelbaum, Harry P. Erba

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'A randomized phase III study of standard versus high-dose cytarabine with or without vorinostat for AML'. Together they form a unique fingerprint.

Medicine & Life Sciences